NewsBenzingaNeedham Maintains Buy on Genpact, Raises Price Target to $55 Needham Maintains Buy on Genpact, Raises Price Target to $55 Benzinga 2026.11.06 13:21 (GMT+0) Open on Benzinga Other news Wells Fargo Maintains Overweight on Century Aluminum, Lowers Price Target to $71 B. Riley Securities Maintains Neutral on Alpha & Omega, Lowers Price Target to $22 Citizens Maintains Market Outperform on Inspired Entertainment, Lowers Price Target to $7 Wells Fargo Maintains Overweight on CRH, Raises Price Target to $107 Citizens Maintains Market Outperform on Halozyme Therapeutics, Raises Price Target to $149 Thermo Fisher Scientific Authorizes $5 Billion Share Buyback after Upbeat Earnings
